Novo Pursues RNA Strategy for Diabetes and Obesity through $550 Million Replicate Agreement

Novo Pursues RNA Strategy for Diabetes and Obesity through $550 Million Replicate Agreement

Novo Pursues RNA Strategy for Diabetes and Obesity through $550 Million Replicate Agreement